Metabolic-immune interactions in gastric cancer T cells:A single-cell atlas for prognostic biomarker identification
摘要Metabolic alterations and immune dysfunction within the gastric tumor microenvironment critically drive gastric cancer(GC)progression and therapeutic resistance.Although single-cell RNA sequencing(scRNA-seq)has unveiled cellular heterogeneity in GC,the metabolic landscapes of tu-mor cells and their interplay with immune components remain underex-plored.By integrating scRNA-seq data from 35,633 cells across 23 GC tissues(GSE150290),bulk RNA-seq data from UCSC Xena,and two in-dependent microarray cohorts(GSE26899,GSE62254),we systematically characterized metabolic heterogeneity and identified immune-related prognostic biomarkers.Reclustering of malignant epithelial cells revealed distinct metabolic phenotypes,with the citrate cycle and oxidative phos-phorylation pathways emerging as key drivers of intratumoral diversity and T cell differentiation.Through machine learning and survival analyses,we discovered a novel risk score model composed of 6 T cell differentiation signatures,which stratified patients into high-and low-risk groups with significant differences in overall survival.Notably,this model outperformed traditional clinicopathological factors in predicting prognosis,validated in both bulk RNA-seq and microarray datasets.Immunohistochemistry further confirmed the prognostic value of key regulatory proteins(RGS1,CXCR4,CTLA4,ARPP19,ZNRF1,and ZNF207).Our findings highlight the meta-bolic immune crosstalk in GC and provide a promising biomarker panel for precision risk stratification and potential immunotherapeutic targets.
更多相关知识
- 浏览10
- 被引0
- 下载0

相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



